ReviewArquivos brasileiros de cardiologia2018

Indications of PCSK9 Inhibitors for Patients at High and Very High Cardiovascular Risk.

Paulo Eduardo Ballvé Behr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.